drugset / Trial / NCT00064402
Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the bronchodilator effect and safety of multiple daily doses of arformoterol administered for 12 weeks as maintenance treatment in patients with COPD
Timeline
- Start
- 2002-04
- Primary completion
- 2004-03
- Completion
- 2004-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Arformoterol | Small molecule | 15 ug | Inhaled |
| Subject | Arformoterol | Small molecule | 25 ug | Inhaled |
| Subject | Arformoterol | Small molecule | 50 ug | Inhaled |
| Comparator | Salmeterol | Other / unclassified | 42 ug | Inhaled |